Origo Biopharma Origo Biopharma, S.L. Innovative small molecules to treat the immune system Origo is a biotech company developing a new generation of therapeutic products for the treatment of several diseases linked to TGF-β in gastrointestinal and lung indications. Founded by biotech/pharma executives from Palobiopharma [...]

Ona Therapeutics Ona Therapeutics, S.L. Novel target to treat metastatic cancer. Spin off from IRB Barcelona based on the research conducted by Dr. Aznar-Benitah in the field of lipid metabolism. Developing a drug targeting metastasis-initiating cells for the treatment of metastatic cancer, a clear unmet [...]